The full blood examination (FBE) test is the most requested pathology test in Australia, and yet, remote Northern Territory (NT) communities do not have timely and reliable access to this fundamental test. This project aims to improve patient access to full blood examination (FBE) testing in remote primary care facilities through implementing a novel point-of-care (POC) FBE testing device (Therapeutic Goods Administration [TGA] Approved) and its delivery model in the NT using a stepped wedge cluster-randomised trial in 21 primary health care centres. The delivery model will primarily be evaluated for its clinical and cost-effectiveness in the early treatment of sepsis. Other conditions to be explored in a include anaemia, chronic kidney disease and respiratory infections.